Xenograft assessment of predictive biomarkers for standard head and neck cancer therapies

Head and neck squamous cell carcinoma (HNSCC) remains a challenging cancer to treat with overall 5-year survival on the order of 50–60%. Therefore, predictive biomarkers for this disease would be valuable to provide more effective and individualized therapeutic approaches for these patients. While p...

Descripción completa

Detalles Bibliográficos
Autores principales: Stein, Andrew P, Swick, Adam D, Smith, Molly A, Blitzer, Grace C, Yang, Robert Z, Saha, Sandeep, Harari, Paul M, Lambert, Paul F, Liu, Cheng Z, Kimple, Randall J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430263/
https://www.ncbi.nlm.nih.gov/pubmed/25619980
http://dx.doi.org/10.1002/cam4.387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430263/
https://www.ncbi.nlm.nih.gov/pubmed/25619980
http://dx.doi.org/10.1002/cam4.387

Ejemplares similares